{"id": "1333922290581581825", "creation": 1606866831.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 2, "like_count": 0, "quote_count": 0}}, "quoted": "1333878583882870785", "text": "\u201c@SerumInstIndia, which has partnered with @AstraZeneca to manufacture its #COVID19 #vaccine, will continue to test a two full dose regimen of the shot despite it showing a lower success rate than a half and full dose regimen in pivotal trials...\u201d #compliance https://t.co/EWpqJTZtCd", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#COMPLIANCE"]}